Morgan Stanley Cortexyme, Inc. Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Cortexyme, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,690 shares of CRTX stock, worth $4,760. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,690
Previous 4,302
14.23%
Holding current value
$4,760
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CRTX
# of Institutions
49Shares Held
12.6MCall Options Held
98.3KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.07MShares$3.97 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$2.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.39MShares$1.79 Million0.0% of portfolio
-
Ieq Capital, LLC981KShares$1.27 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M